Matrixyl
Also called palmitoyl pentapeptide-4, pal-KTTKS
Matrixyl is a tiny fragment of collagen with a fatty tail attached so it can get through skin.
Studied in people, in small numbers. The ranges below lean mostly on community-reported dosing and results — what people run, and what they say happened.
- Skin & hair
The quick answer
Matrixyl is a tiny fragment of collagen with a fatty tail attached so it can get through skin. The fragment is the same piece your skin releases when collagen breaks down - so putting it on is essentially telling your skin that collagen has been damaged and more is needed. It is a message, not an ingredient.
What it is not
Not a retinoid, and not a substitute for sun protection.
Why people use it
🧴 Topical - no injection at all; ✨ Fine lines and firmness over months; 🤝 Layers with almost everything; 😌 Tolerated by people who cannot use retinoids
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
People report running this anywhere from 3% to 8%, twice daily.Where somebody sits in that range depends on what they are using it for and what they are starting from — the low end is a deliberate choice a lot of people make, not a half-hearted version of the high end.
Skin & hair
- How often
- Twice daily
- Route
- topical
- Where this comes from
- Small human studies
Fine lines and firmness over two to three months.
What to expect, and when
Month 1: hydration and texture. Month 2-3: fine lines. Month 4-6: firmness, which is where before-and-after photos start to show it.
Side effects, and what people do about them
Among the gentlest actives in skincare. Occasional irritation, usually traced to the rest of the formula rather than the peptide.
Go deeper
Open these only if you want them.
How it actually works
Palmitoyl pentapeptide-4 (pal-KTTKS). The KTTKS sequence is a fragment of type I collagen that signals fibroblasts to increase collagen and glycosaminoglycan synthesis; the palmitoyl tail supplies the fat solubility needed to cross the outer layer of skin.
More on the evidence
Small topical human trials. A cosmetic ingredient, not an injectable.
What people report, in full
The skincare community's verdict on Matrixyl is settled, and it is worth hearing because it is unusually consistent: it works, slowly, and it is not a retinoid. The people who report disappointment are the ones who expected retinoid-scale results in a month; the people who ran it three to six months and took photographs describe real change in fine lines and firmness. Its genuine niche in the discussion is as the option for skin that cannot tolerate retinoids and for people who are pregnant, and it gets recommended for that constantly. Two practical points repeat: the concentration in the finished product matters far more than the brand name, and it layers with everything, which is why it usually shows up as a supporting ingredient rather than a headline one.
Worth knowing
The trials are real. They were not asking the question most people are asking when they come looking for this one.
Small cosmetic-scale human studies, generally positive, with modest effects honestly reported.
Sources and review
This record is built on what the wider community reports doing and experiencing, summarised above. No counted dataset has been attached to this compound yet — when one is published, it goes here with its numbers.
These references were located by literature search and recorded as the primary sources behind this record. The publishers block automated retrieval, so they are pointers to the right papers rather than quotations we have checked line by line. They are replaced as we read them properly.
Last reviewed 2026-09-08.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about Matrixyl